Vantive

👥 3,731 employees💰 Last funded Feb 2025
Vantive is a vital organ therapy company on a mission to extend lives and expand possibilities for patients and care teams globally. For 70 years, our team has driven meaningful innovations in kidney care. Today, Vantive’s people, solutions and services deliver over 1 million touchpoints each day to patients around the world. As we build on our legacy, we are focused on elevating the dialysis experience through digital solutions and advanced services, while looking beyond kidney care and investing in transforming vital organ therapies. Our goal is to provide therapies that fit more easily into providers’ practices and patients’ lives. Greater flexibility and efficiency in therapy administration for care teams, and longer, fuller lives for patients— that is what Vantive aspires to deliver.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Vantive?
Vantive has 1 investors on record on gritt.io.
When did Vantive last raise funding?
The most recent investment in Vantive recorded on gritt.io was in February 2025.
What industry is Vantive in?
Vantive operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.